-

What Cannabis Companies Are Facing in a Shifting Economy
In 2025, the U.S. cannabis industry remains a burgeoning sector—but it is increasingly sensitive to the health of the broader economy. As economic growth slows, interest rates stay elevated, and investor appetite wanes, cannabis companies find themselves at the intersection of optimism and caution. Economic slow‑down and reduced investment After years of rapid expansion, the… Continue Reading →
-

From High Expectations to Reality: U.S. Cannabis Growth Moderates
Current Growth Patterns Legalization Momentum Has Slowed Key Headwinds Oversupply and Price Pressure Regulatory Burdens & Illegal Competition Investor Sentiment & Valuations Environmental and Operational Pressures Opportunities & Forward Focus Final Thoughts While the U.S. cannabis industry continues to grow in absolute terms, the pace of growth is clearly slowing. The legalization wave that drove… Continue Reading →
-

When Profit Hits the Ceiling: Cannabis Companies Strangled by 280E
The federal Internal Revenue Code Section 280E, originally enacted in 1982 to prevent drug traffickers from deducting business expenses for Schedule I or II substances, continues to impose severe constraints on state-licensed cannabis businesses. While operators may deduct cost of goods sold (COGS), they are barred from deducting ordinary and necessary business expenses such as… Continue Reading →





